CTSO Stock Analysis: Buy, Sell, or Hold?
CTSO - Cytosorbents Corp.
$0.38
0.00 (-0.34%)
▼
5d:
-11.63%
30d:
-7.54%
90d:
-37.7%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When CTSO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CTSO is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CTSO is down 11.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CTSO is currently trading at $0.38, which is considered slightly low relative to its 30-day fair value range of $0.38 to $0.45.
Technical Outlook: Technically, CTSO is in a strong downtrend. The price is currently testing key support at $0.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.88 (+656.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CTSO is in a strong downtrend. The price is currently testing key support at $0.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.88 (+656.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.38 -
$0.45
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 656.6% below Wall St target ($2.88)
- WARNING: Recommendation downgraded due to -11.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.38 -
$0.45
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.37
Resistance Level
$0.53
Current Trend
Strong Downtrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.20
Wall Street Target
$2.88
(+656.6%)
Revenue Growth (YoY)
1.6%
Profit Margin
-31.9%
Share & Embed Analysis
Last updated: July 14, 2026 5:38 AM ET
Data refreshes hourly during market hours. Next update: 6:38 AM
Data refreshes hourly during market hours. Next update: 6:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTSO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 62 BUY |
